EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Real-world safety and effectiveness of olaparib maintenance after first-relapse platinum-sensitive ovarian cancer in Japan: a multicenter historical cohort (JGOG3026)

Kosuke Yoshihara iD, Terumi Tanigawa iD, Shin Nishio iD, Hiroyuki Kanao iD, Yasunori Yoshino iD, Ayako Mochizuki iD, Sari Nakao iD, Tatsuo Kagimura iD, Hiroshi Tanabe iD, Hiroaki Kajiyama iD, Muneaki Shimada iD, Aikou Okamoto iD und 1 weitere

Journal of Gynecologic Oncology · 2027 · 38

DOI: 10.3802/jgo.2027.38.e5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2027. Verfasst von Kosuke Yoshihara und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Japanese Gynecologic Oncology Group.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ChemotherapyOvarian CancerPoly(ADP-ribose) Polymerase InhibitorsRecurrence

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Department of Gynecologic Oncology, Cancer Institute Hospital, Tokyo, Japan.
  • Department of Gynecologic Oncology, Nagasaki Harbor Medical Center, Nagasaki, Japan.
  • Department of Obstetrics and Gynecology, Kurume University School of Medicine, Fukuoka, Japan.
  • Department of Gynecology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Department of Gynecologic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.

ORCID-Profile: Kosuke Yoshihara, Terumi Tanigawa, Shin Nishio, Hiroyuki Kanao, Yasunori Yoshino, Ayako Mochizuki, Sari Nakao, Tatsuo Kagimura, Hiroshi Tanabe, Hiroaki Kajiyama, Muneaki Shimada, Aikou Okamoto, Takayuki Enomoto

Förderung

  • The Japanese Gynecologic Oncology Group

Zitieren

APA

Yoshihara, K., Tanigawa, T., Nishio, S., Kanao, H., Yoshino, Y., Mochizuki, A., Nakao, S., Kagimura, T., Tanabe, H., Kajiyama, H., Shimada, M., Okamoto, A., & Enomoto, T. (2027). Real-world safety and effectiveness of olaparib maintenance after first-relapse platinum-sensitive ovarian cancer in Japan: a multicenter historical cohort (JGOG3026). Journal of Gynecologic Oncology, 38. https://doi.org/10.3802/jgo.2027.38.e5

Vancouver

Yoshihara K, Tanigawa T, Nishio S, Kanao H, Yoshino Y, Mochizuki A, et al. Real-world safety and effectiveness of olaparib maintenance after first-relapse platinum-sensitive ovarian cancer in Japan: a multicenter historical cohort (JGOG3026). Journal of Gynecologic Oncology. 2027;38. doi:10.3802/jgo.2027.38.e5

BibTeX
@article{Yoshihara2027,
  author = {Yoshihara, Kosuke and Tanigawa, Terumi and Nishio, Shin and Kanao, Hiroyuki and Yoshino, Yasunori and Mochizuki, Ayako and Nakao, Sari and Kagimura, Tatsuo and Tanabe, Hiroshi and Kajiyama, Hiroaki and Shimada, Muneaki and Okamoto, Aikou and Enomoto, Takayuki},
  title = {Real-world safety and effectiveness of olaparib maintenance after first-relapse platinum-sensitive ovarian cancer in Japan: a multicenter historical cohort (JGOG3026)},
  journal = {Journal of Gynecologic Oncology},
  year = {2027},
  volume = {38},
  doi = {10.3802/jgo.2027.38.e5}
}
Kostenlos starten →